Research Article

Zinc Deficiency and the Recurrence of Clostridium difficile Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study

Table 3

Low zinc cohort characteristics.

Not supplemented (n = 6)Supplemented (n = 25)Total (n = 31) valueTest utilized

Zinc
Serum zinc (mcg/ml) (SD)0.53 (0.08)0.52 (0.08)0.52 (0.08)0.907t-test
Patient characteristics
Age, mean (SD)75.33 (12.03)66.72 (18.90)68.39 (17.94)0.299t-test
Female gender, n (%)4 (66.67)12 (48.00)16 (51.61)0.654Fischer’s exact
BMI, mean (SD)24.62 (5.34)27.78 (8.93)27.17 (8.37)0.417t-test
Immunocompromised state, n (%)1 (16.67)7 (28.00)8 (25.81)1.000
Charlson Comorbidity Index, mean (SD)2.00 (2.68)2.12 (2.13)2.10 (2.20)0.907
IBD, n (%)1 (16.67)9 (36.00)10 (32.26)0.634Fischer’s exact
 Ulcerative colitis, n134
 Crohn’s colitis, n022
 Indeterminate colitis, n044
CDI history
# CDIs, mean (SD)4.83 (1.47)3.92 (1.41)4.10 (1.45)0.168t-test
# CDIs 6 mo before FMT, mean (SD)3.17 (1.17)2.64 (1.08)2.74 (1.09)0.298t-test
# CDI-hospitalizations, mean (SD)2.33 (2.42)0.96 (1.10)1.23 (1.50)0.228t-test
# CDI-hospitalizations 6 mo before FMT, mean (SD)1.50 (1.64)0.68 (0.80)0.84 (1.04)0.283t-test

SD, standard deviation; BMI, body mass index; CDI, Clostridium difficile infection; IBD, inflammatory bowel disease; FMT, fecal microbiota transplant; mo, month.